QTMI is designed to measure heterogeneity and treatment response of disease in marrow. It does this by isolating the marrow from images (PET/CT, dual-energy CT or MRI) and analyzing the marrow on a whole patient level as well as by skeletal region. AIQ’s patented technology allows precise measurement of change in marrow over time, providing unique and powerful insights into the response of disease.
QTMI targets cancer in marrow (e.g., Acute Myeloid Leukemia)
Currently in development.
NOT CLEARED FOR USE IN THE UNITED STATES.
Vanderhoek M, Perlman SB, Jeraj R. Impact of different standardized uptake value measures on PET-based quantification of treatment response. J Nucl Med. 2013;54(8):1188-1194.
Perk TG, Weisse NA, Yip SSF, Jeraj R. A method for quantitative total marrow imaging (QTMI) with PET/CT. Biomed Phys Eng Express.2016;2:055006.